Long-Term Outcomes Following Trabeculectomy Combined with 25-Gauge Transconjunctival Sutureless Vitrectomy in Uveitis Patients

Ocul Immunol Inflamm. 2015 Jun;23(3):212-8. doi: 10.3109/09273948.2014.892626. Epub 2014 Mar 21.

Abstract

Purpose: To evaluate the efficacy of combined trabeculectomy (TLE) and 25-gauge transconjunctival sutureless vitrectomy (TSV-25) for uveitis patients.

Methods: Combined TSV-25/TLE was performed in 9 eyes of 6 patients with vitreoretinal complications and intractable glaucoma. Visual acuity, intraocular pressure (IOP), inflammatory control, and number of hypotensive medications were evaluated.

Results: Visual acuity improved in 7 of 9 eyes and inflammation was controlled with a decreased oral anti-inflammatory agent dosage in all eyes. Mean IOP, which was 28.11 ± 4.83 mmHg preoperatively, was significantly reduced (15.77 ± 2.68 mmHg) 5 years after surgery (p = 0.008). The mean number of IOP-lowering medications was 3.33 ± 0.71 before surgery and 1.11 ± 0.92 5 years after surgery (p = 0.007). Two eyes required implant of an Ahmed drainage valve during the follow-up period.

Conclusion: Combined TSV-25/TLE can be effective in managing vitreoretinal complications and elevated IOP in uveitis patients.

Keywords: 25-gauge vitrectomy; intraocular pressure; pars planar vitrectomy; trabeculectomy; uveitis.

MeSH terms

  • Adult
  • Conjunctiva / surgery*
  • Female
  • Follow-Up Studies
  • Glaucoma / complications
  • Glaucoma / physiopathology
  • Glaucoma / surgery*
  • Humans
  • Intraocular Pressure
  • Male
  • Middle Aged
  • Retrospective Studies
  • Suture Techniques*
  • Time Factors
  • Trabeculectomy / methods*
  • Treatment Outcome
  • Uveitis / complications
  • Uveitis / physiopathology
  • Uveitis / surgery*
  • Visual Acuity
  • Vitrectomy / methods*